Nevertheless, a combined treatment of LSD1 inhibitors with other therapeutic targets (Fang et al. 2019), already supposed by Fang et al. (2019), may be also of interest for future investigations of LSD1 and GPER in cervical cancer. The gene discussed is GPER1; the disease is cervical cancer.